Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-027601

EVP and Chief Legal Officer sold 4,378 shares at $45.00 ($197,010)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and Chief Legal Officer 2023-05-04 Sale −4,378 $45.00 $197,010 51,982 D: show line 1 in the form
Open-market sales · 4,378 sh · avg $45.00 · $197,010
Loading xslF345X04/doc4.xml…